NCT06312813View on ClinicalTrials.gov

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

PHASE2RecruitingINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2028

Conditions

Rosacea

Interventions

DRUG

Imipramine

4% imipramine

DRUG

Amitriptyline

4% amitriptyline

DRUG

Vehicle

0.1ml propylene glycol

Trial Locations (1)

45324

RECRUITING

Wright State Physicians, Fairborn

All Listed Sponsors

lead

Wright State University

OTHER